ALGS Past Earnings image   This ALGS past earnings page last updated 5/8/2023
ALGS Past Earnings
PeriodPast Earnings DateGAAP
Q1 20235/4/2023-0.530
Q4 20223/9/2023-0.510
Q3 202211/2/2022-0.440
Q2 20228/4/2022-0.470
Q1 20225/4/2022-0.840
Q4 20213/10/2022-0.890
Q3 202111/4/2021-0.780
Q2 20218/5/2021-0.790
Q1 20215/10/2021-0.740
Q4 20203/23/2021-1.090
Q3 202011/25/2020-11.000
ALGS Past Revenue
PeriodPast Earnings DateGAAP
Q1 20235/4/20230.00B
Q4 20223/9/20230.00B
Q3 202211/2/20220.00B
Q2 20228/4/20220.00B
Q1 20225/4/20220.00B
Q4 20213/10/20220.00B
Q3 202111/4/20210.00B
Q2 20218/5/20210.00B
Q1 20215/10/20210.00B
Q4 20203/23/2021NA
Q3 202011/25/2020NA
Quotes delayed 20 minutes

Email EnvelopeFree ALGS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Aligos Therapeutics (ALGS) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

ALHC Past Earnings
ALIM Past Earnings
ALKS Past Earnings
ALLK Past Earnings
ALLO Past Earnings
ALNA Past Earnings
ALNY Past Earnings
ALPN Past Earnings
ALRN Past Earnings
ALT Past Earnings

ALGS Past Earnings Q&A

What was the best and worst ALGS past earnings results?
For Aligos Therapeutics, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest ALGS past earnings result in our data set was -0.440/share posted in Q3 2022, while the lowest was in Q3 2020 when ALGS posted -11.000/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q3 2022 when ALGS reported 0.00B in revenue, while the quarter with the lowest revenue in our data set was Q4 2020 at NA of revenue.

  Suggested answer: There are 11 ALGS past earnings results in our data set.

On this page we presented the ALGS past earnings date information for Aligos Therapeutics. Reviewing that ALGS Past Earnings for the company, we see that the highest past earnings result in our data set was in Q3 2022, when ALGS posted gaap of -0.440/share. Meanwhile the lowest ALGS past earnings result was in Q3 2020, when ALGS posted gaap of -11.000/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q3 2022 when ALGS reported 0.00B in revenue, while the smallest revenue quarter was Q4 2020 when ALGS reported NA in revenue.

Any self directed investor doing their due diligence on ALGS or any other given stock can benefit from researching all of the Aligos Therapeutics past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you to make it easy for investors to investigate Aligos Therapeutics past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for ALGS. Thanks for visiting, and the next time you need to research ALGS past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: Institutional Holders of ALTR, Institutional Holders of BQR, RFMZ Videos.


ALGS Past Earnings | | Copyright © 2020 - 2023, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.